| scholarly article | Q13442814 |
| P50 | author | Steven J. Burakoff | Q7614852 |
| Barbara Bierer | Q42698866 | ||
| Eileen Remold-O'Donnell | Q90240432 | ||
| P2093 | author name string | F S Rosen | |
| S J Mentzer | |||
| M A Crimmins | |||
| P2860 | cites work | Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen) | Q24296933 |
| Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol) | Q24527312 | ||
| Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes | Q28279948 | ||
| Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. | Q33483562 | ||
| The primary immunodeficiencies. (2). | Q34055709 | ||
| Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome | Q36348858 | ||
| Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens | Q40104989 | ||
| Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes | Q40661779 | ||
| Complete Correction of the Wiskott-Aldrich Syndrome by Allogeneic Bone-Marrow Transplantation | Q40882151 | ||
| Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines | Q58065088 | ||
| An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein | Q58960509 | ||
| Identification of a glycophorin-like molecule at the cell surface of rat thymocytes | Q59079779 | ||
| The large sialoglycoprotein of human lymphocytes. I. Distribution on T and B lineage cells as revealed by a monospecific chicken antibody | Q67288095 | ||
| Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome | Q69517183 | ||
| Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome | Q69659159 | ||
| Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies | Q69946768 | ||
| Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells | Q69960764 | ||
| Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome | Q70099368 | ||
| Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells | Q71441581 | ||
| Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution | Q71474584 | ||
| Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome | Q72512237 | ||
| A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells | Q72673068 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| Wiskott-Aldrich syndrome | Q953638 | ||
| P304 | page(s) | 1383-1392 | |
| P577 | publication date | 1987-05-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation | |
| P478 | volume | 165 |
| Q41557661 | A new CD43 monoclonal antibody induces homotypic aggregation of human leucocytes through a CD11a/CD18-dependent and -independent mechanism. |
| Q34263537 | A novel X-linked combined immunodeficiency disease |
| Q28268565 | A short, novel promoter sequence confers the expression of human leukosialin, a major sialoglycoprotein on leukocytes |
| Q37863466 | Accessory cell signals involved in T-cell activation |
| Q54259667 | Activated Protein Kinase C Directly Phosphorylates the CD34 Antigen in Acute Lymphoblastic Leukemia Cells |
| Q38375267 | Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen |
| Q41822286 | Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies |
| Q36361027 | Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome |
| Q24563353 | Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin) |
| Q34244993 | Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome |
| Q28577401 | An antiserum raised against the recombinant cytoplasmic tail of the human CD43 glycoprotein identifies CD43 in many mammalian species |
| Q33887637 | Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses |
| Q68425602 | CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA |
| Q70888061 | CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study |
| Q41154331 | CD43 expression in a B cell lymphoma, WEHI 231, reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion |
| Q33615793 | CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA. |
| Q42742267 | CD43 is a ligand for E-selectin on CLA+ human T cells |
| Q28586182 | CD43 is a murine T cell costimulatory receptor that functions independently of CD28 |
| Q68832717 | CD43 monoclonal antibodies recognize the large sialoglycoprotein of human leukocytes |
| Q24296934 | CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1 |
| Q33784039 | CD43, a molecule with multiple functions |
| Q36264320 | CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes |
| Q28141639 | CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes |
| Q30176770 | CD43-specific activation of T cells induces association of CD43 to Fyn kinase |
| Q38351915 | Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells |
| Q24624142 | Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16 |
| Q69376966 | Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome |
| Q33350750 | Coincident Kaposi sarcoma and T‐cell lymphoma in a patient with the Wiskott‐Aldrich syndrome |
| Q28582916 | Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons |
| Q39545257 | Definition of the gene loci in X-linked immunodeficiencies |
| Q41588273 | Differential epitope expression of Ly-48 (mouse leukosialin) |
| Q28236017 | Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils |
| Q34786830 | Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival |
| Q40727782 | Engagement of CD43 enhances human immunodeficiency virus type 1 transcriptional activity and virus production that is induced upon TCR/CD3 stimulation |
| Q24303591 | Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome |
| Q41343146 | Expression of the T antigen on a T-lymphoid cell line, supT1. |
| Q35197829 | Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome |
| Q41095926 | Hodgkin's cells express a novel pattern of adhesion molecules |
| Q36353594 | Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes |
| Q71606754 | Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells |
| Q70383856 | Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes |
| Q41106276 | Leukosialin (CD43) is proteolytically cleaved from stimulated HMC-1 cells. |
| Q41154455 | Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation |
| Q41357001 | MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation |
| Q36578210 | Molecular Events Mediating T Cell Activation |
| Q73827686 | Molecular basis for X-linked immunodeficiencies |
| Q40403069 | Molecular characterization of CD34+ human hematopoietic progenitor cells |
| Q24617856 | Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome |
| Q39627385 | Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen |
| Q41452471 | Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. |
| Q74405453 | Negative regulation of T cell homing by CD43 |
| Q28508953 | Negative regulation of T-cell adhesion and activation by CD43 |
| Q38263240 | Non-antigen-specific triggering signals for human cytotoxic T lymphocytes |
| Q40607190 | Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF. |
| Q52048972 | Parallel pattern of expression of CD43 and of LFA-1 on the CD45RA+ (naive) and CD45RO+ (memory) subsets of human CD4+ and CD8+ cells. Correlation with the aggregative response of the cells to CD43 monoclonal antibodies. |
| Q45060790 | Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell lines |
| Q42636768 | Protein sequence and gene structure for mouse leukosialin (CD43), a T lymphocyte mucin without introns in the coding sequence |
| Q44912757 | Reduced CD43 expression on the neutrophils of MDS patients correlates with an activated phenotype of these cells |
| Q36230070 | Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow |
| Q24527369 | Structure of the human sialophorin (CD43) gene. Identification of features atypical of genes encoding integral membrane proteins |
| Q39524176 | Surface proteins and glycoproteins of human leucocytes |
| Q28272069 | T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation |
| Q38249158 | T-cell responses to Mls and to bacterial proteins that mimic its behavior |
| Q40933929 | The CBF.78 monoclonal antibody to human sialophorin has distinct properties giving new insights into the CD43 marker and its activation pathway |
| Q67554448 | The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells |
| Q38491162 | The human counterpart of mouse B-1 cells |
| Q41359613 | The sequence of rat leukosialin (W3/13 antigen) reveals a molecule with O-linked glycosylation of one third of its extracellular amino acids |
| Q38306196 | Transcriptional activation of human leukosialin (CD43) gene by Sp1 through binding to a GGGTGG motif |
| Q28139359 | Waltzing with WASP |
| Q33493814 | Wiskott Aldrich syndrome: an immunodeficiency syndrome not rare in Western Australia |
| Q36958643 | Wiskott-Aldrich syndrome: a multidisciplinary disease |
| Q39654941 | Wiskott-Aldrich syndrome: new perspectives in pathogenesis and management. |
| Q48279733 | cDNA cloning and localization of the mouse leukosialin gene (Ly48) to chromosome 7. |
Search more.